Related Experiment Video
Updated: Jul 11, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Contraceptive discontinuation attributed to method dissatisfaction in the United States
Caroline Moreau1, Kelly Cleland, James Trussell
1Office of Population Research, Princeton University, Wallace Hall, Princeton, NJ 08544, USA. cmoreau@princeton.edu
Background:
This study examines contraceptive discontinuation due to method dissatisfaction among women in the United States.
Study Design:
The study population, drawn from the 2002 National Survey of Family Growth, consisted of 6724 women (15-44 years of age) who had ever used a reversible contraceptive method. We first estimated the overall proportion of women who had ever discontinued their contraceptive due to dissatisfaction. We then calculated method-specific discontinuation risks due to dissatisfaction and analyzed the reasons for dissatisfaction given by women who had ever stopped using Norplant, Depo-Provera, oral contraceptives or condoms.
Results:
Overall, 46% of women had ever discontinued at least one method because they were unsatisfied with it. Dissatisfaction-related discontinuation risks varied widely by method: the diaphragm and cervical cap showed the highest proportions of such discontinuation (52%), followed by long-acting hormonal methods (42%). Oral contraceptives were associated with an intermediate risk of dissatisfaction-related discontinuation (29%), while condoms had the lowest risk (12%).
Conclusion:
A broader understanding of women's concerns and experiences using contraception could help health care providers redesign counseling strategies to improve contraceptive continuation.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Oral Drug Delivery Systems: Continuous-Release Systems
Ending Relationships